JPS63502117A - 放出を制御されたリポソ−ム供給系 - Google Patents
放出を制御されたリポソ−ム供給系Info
- Publication number
- JPS63502117A JPS63502117A JP50177387A JP50177387A JPS63502117A JP S63502117 A JPS63502117 A JP S63502117A JP 50177387 A JP50177387 A JP 50177387A JP 50177387 A JP50177387 A JP 50177387A JP S63502117 A JPS63502117 A JP S63502117A
- Authority
- JP
- Japan
- Prior art keywords
- liposomes
- liposome
- composition
- compound
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82815386A | 1986-02-10 | 1986-02-10 | |
US828153 | 1986-02-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63502117A true JPS63502117A (ja) | 1988-08-18 |
Family
ID=25251035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50177387A Pending JPS63502117A (ja) | 1986-02-10 | 1987-02-09 | 放出を制御されたリポソ−ム供給系 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0256119A4 (fr) |
JP (1) | JPS63502117A (fr) |
AU (1) | AU7128887A (fr) |
WO (1) | WO1987004592A1 (fr) |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07116077B2 (ja) * | 1987-02-02 | 1995-12-13 | エクソン ケミカル パテンツ,インコーポレイテッド | 有機酸変性重合体膜を使用するアルコールの回収法 |
JP2011219482A (ja) * | 1997-06-27 | 2011-11-04 | Abraxis Bioscience Llc | 薬理薬物の新規製剤、その製造法及びその使用法 |
JP2012092148A (ja) * | 2000-06-30 | 2012-05-17 | Tekmira Pharmaceuticals Corp | リポソーム抗新生物薬剤およびその使用 |
US8668937B2 (en) | 2011-03-17 | 2014-03-11 | Transdermal Biotechnology, Inc. | Topical nitric oxide systems and methods of use thereof |
US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
US8871258B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
US8871260B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
US9050248B2 (en) | 2002-05-31 | 2015-06-09 | Transdermal Biotechnology, Inc. | Methods of delivering stable topical drug compositions |
US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9585931B2 (en) | 2013-03-13 | 2017-03-07 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9597401B2 (en) | 2013-03-13 | 2017-03-21 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9597400B2 (en) | 2013-03-13 | 2017-03-21 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US10034914B2 (en) | 2013-03-13 | 2018-07-31 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US10226511B2 (en) | 2013-03-13 | 2019-03-12 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5916588A (en) * | 1984-04-12 | 1999-06-29 | The Liposome Company, Inc. | Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use |
US6090406A (en) * | 1984-04-12 | 2000-07-18 | The Liposome Company, Inc. | Potentiation of immune responses with liposomal adjuvants |
US4822605A (en) * | 1986-02-18 | 1989-04-18 | Exovir, Inc. | Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
FR2624741B1 (fr) * | 1987-12-21 | 1991-06-28 | Pasteur Institut | Compositions a base d'une combinaison de liposomes et de lymphokine presentant des proprietes immunostimulantes et leurs applications en medecine humaine et veterinaire |
AU4525589A (en) * | 1988-10-27 | 1990-05-14 | Regents Of The University Of Minnesota | Liposome immunoadjuvants containing il-2 |
US5091188A (en) * | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
US5246707A (en) * | 1990-04-26 | 1993-09-21 | Haynes Duncan H | Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes |
AU3423493A (en) * | 1991-12-31 | 1993-07-28 | Zymogenetics Inc. | Methods and compositions for reducing blood loss |
WO1995001163A1 (fr) * | 1992-01-03 | 1995-01-12 | Corbiere Jerome | Nouvelles preparations pharmaceutiques a base de peptides pour la voie generale |
FR2685868B1 (fr) * | 1992-01-03 | 1995-06-23 | Corbiere Jerome | Nouvelles preparations pharmaceutiques a base de peptides pour la voie generale. |
KR940011013A (ko) * | 1992-11-27 | 1994-06-20 | 최근선 | 서방성 소마트로핀 제제의 제조방법 |
ES2072223B1 (es) * | 1993-11-25 | 1996-03-16 | Lipotec Sa | Liposomas encapsulando doxorubicina. |
DE4402867C1 (de) * | 1994-01-31 | 1995-06-14 | Rentschler Arzneimittel | Liposomen enthaltend darin verkapselte Proteine, Verfahren zu ihrer Herstellung sowie diese Liposomen enthaltende pharmazeutische und kosmetische Zubereitungen |
US6007838A (en) * | 1995-06-07 | 1999-12-28 | The United States Of America As Represented By The Secretary Of The Army | Process for making liposome preparation |
EP1720521A4 (fr) * | 2004-02-10 | 2008-11-05 | Barnes Jewish Hospital | Efficacite et securite ameliorees d'agents particulaires diriges a l'aide de systemes leurres |
WO2007049279A2 (fr) * | 2005-10-26 | 2007-05-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Combinaison de liposomes et utilisations |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4394448A (en) * | 1978-02-24 | 1983-07-19 | Szoka Jr Francis C | Method of inserting DNA into living cells |
-
1987
- 1987-02-09 AU AU71288/87A patent/AU7128887A/en not_active Abandoned
- 1987-02-09 EP EP19870901859 patent/EP0256119A4/fr not_active Withdrawn
- 1987-02-09 WO PCT/US1987/000285 patent/WO1987004592A1/fr not_active Application Discontinuation
- 1987-02-09 JP JP50177387A patent/JPS63502117A/ja active Pending
Cited By (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07116077B2 (ja) * | 1987-02-02 | 1995-12-13 | エクソン ケミカル パテンツ,インコーポレイテッド | 有機酸変性重合体膜を使用するアルコールの回収法 |
JP2011219482A (ja) * | 1997-06-27 | 2011-11-04 | Abraxis Bioscience Llc | 薬理薬物の新規製剤、その製造法及びその使用法 |
US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
JP2012092148A (ja) * | 2000-06-30 | 2012-05-17 | Tekmira Pharmaceuticals Corp | リポソーム抗新生物薬剤およびその使用 |
US9050248B2 (en) | 2002-05-31 | 2015-06-09 | Transdermal Biotechnology, Inc. | Methods of delivering stable topical drug compositions |
US9060925B2 (en) | 2002-05-31 | 2015-06-23 | Transdermal Biotechnology, Inc. | Methods of delivering stable topical drug compositions |
US8668937B2 (en) | 2011-03-17 | 2014-03-11 | Transdermal Biotechnology, Inc. | Topical nitric oxide systems and methods of use thereof |
US9937202B2 (en) | 2011-03-17 | 2018-04-10 | Transdermal Biotechnology, Inc. | Topical nitric oxide systems and methods of use thereof |
US9517179B2 (en) | 2011-03-17 | 2016-12-13 | Transdermal Biotechnology, Inc. | Topical nitric oxide systems and methods of use thereof |
US9480705B2 (en) | 2012-09-19 | 2016-11-01 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
US9480711B2 (en) | 2012-09-19 | 2016-11-01 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
US8871260B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
US9198853B2 (en) | 2012-09-19 | 2015-12-01 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
US9198970B2 (en) | 2012-09-19 | 2015-12-01 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
US9198930B2 (en) | 2012-09-19 | 2015-12-01 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
US9198931B2 (en) | 2012-09-19 | 2015-12-01 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
US10034896B2 (en) | 2012-09-19 | 2018-07-31 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
US9198933B2 (en) | 2012-09-19 | 2015-12-01 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
US9198854B2 (en) | 2012-09-19 | 2015-12-01 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
US9205043B2 (en) | 2012-09-19 | 2015-12-08 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
US9295638B2 (en) | 2012-09-19 | 2016-03-29 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
US9480708B2 (en) | 2012-09-19 | 2016-11-01 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
US10034897B2 (en) | 2012-09-19 | 2018-07-31 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
US10034898B2 (en) | 2012-09-19 | 2018-07-31 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
US9968635B2 (en) | 2012-09-19 | 2018-05-15 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
US9968634B2 (en) | 2012-09-19 | 2018-05-15 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
US9950004B2 (en) | 2012-09-19 | 2018-04-24 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
US9844565B2 (en) | 2012-09-19 | 2017-12-19 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
US9827266B2 (en) | 2012-09-19 | 2017-11-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
US9795632B2 (en) | 2012-09-19 | 2017-10-24 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
US9198932B2 (en) | 2012-09-19 | 2015-12-01 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
US8871258B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
US9480707B2 (en) | 2012-09-19 | 2016-11-01 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
US9480706B2 (en) | 2012-09-19 | 2016-11-01 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
US9480710B2 (en) | 2012-09-19 | 2016-11-01 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
US9480709B2 (en) | 2012-09-19 | 2016-11-01 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
US10080768B2 (en) | 2013-03-13 | 2018-09-25 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9439926B2 (en) | 2013-03-13 | 2016-09-13 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9498535B2 (en) | 2013-03-13 | 2016-11-22 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9585931B2 (en) | 2013-03-13 | 2017-03-07 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9585829B2 (en) | 2013-03-13 | 2017-03-07 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9597400B2 (en) | 2013-03-13 | 2017-03-21 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9636291B2 (en) | 2013-03-13 | 2017-05-02 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
US9682102B2 (en) | 2013-03-13 | 2017-06-20 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9687504B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9694029B2 (en) | 2013-03-13 | 2017-07-04 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9694083B2 (en) | 2013-03-13 | 2017-07-04 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US9700626B2 (en) | 2013-03-13 | 2017-07-11 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9717680B2 (en) | 2013-03-13 | 2017-08-01 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9757467B2 (en) | 2013-03-13 | 2017-09-12 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US9827316B2 (en) | 2013-03-13 | 2017-11-28 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9480642B2 (en) | 2013-03-13 | 2016-11-01 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
US9844506B2 (en) | 2013-03-13 | 2017-12-19 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US9872818B2 (en) | 2013-03-13 | 2018-01-23 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9913793B2 (en) | 2013-03-13 | 2018-03-13 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9931370B2 (en) | 2013-03-13 | 2018-04-03 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9937221B2 (en) | 2013-03-13 | 2018-04-10 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
US9943562B2 (en) | 2013-03-13 | 2018-04-17 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9956290B2 (en) | 2013-03-13 | 2018-05-01 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
US10028994B2 (en) | 2013-03-13 | 2018-07-24 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
US9597401B2 (en) | 2013-03-13 | 2017-03-21 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US10034828B2 (en) | 2013-03-13 | 2018-07-31 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
US10034944B2 (en) | 2013-03-13 | 2018-07-31 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US10034914B2 (en) | 2013-03-13 | 2018-07-31 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US10064955B2 (en) | 2013-03-13 | 2018-09-04 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US10071117B2 (en) | 2013-03-13 | 2018-09-11 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9585817B2 (en) | 2013-03-13 | 2017-03-07 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US10155048B2 (en) | 2013-03-13 | 2018-12-18 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US10188603B2 (en) | 2013-03-13 | 2019-01-29 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
US10213457B2 (en) | 2013-03-13 | 2019-02-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US10226511B2 (en) | 2013-03-13 | 2019-03-12 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
Also Published As
Publication number | Publication date |
---|---|
EP0256119A4 (fr) | 1988-08-23 |
EP0256119A1 (fr) | 1988-02-24 |
WO1987004592A1 (fr) | 1987-08-13 |
AU7128887A (en) | 1987-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS63502117A (ja) | 放出を制御されたリポソ−ム供給系 | |
DE69531701T2 (de) | Sphingosome mit verbesserter arzneistoffabgage | |
US5023087A (en) | Efficient method for preparation of prolonged release liposome-based drug delivery system | |
JP2792702B2 (ja) | 乾燥時に改善された安定性を示すリポソームの調製方法 | |
JP3676976B2 (ja) | 多胞状リポソームへの薬剤封入量の調節 | |
RU2162689C2 (ru) | Пролипосомные порошки для ингаляции | |
Bhaskaran et al. | Comparative evaluation of niosome formulations prepared by different techniques | |
JP5017035B2 (ja) | プロスタグランジンe1を含むエマルション組成物 | |
JP2001510451A (ja) | 弱塩基性薬物を担持するイオン運搬体―中介リポゾーム | |
JPH0834745A (ja) | アルファトコフェロールをベースにした小胞体 | |
EP0731689A1 (fr) | Procede permettant d'augmenter la stabilite de suspensions de liposomes contenant des principes actifs hydrophiles | |
CN104703594B (zh) | 稳定的封装奥沙利铂的脂质体的水分散体及其稳定化方法 | |
Séjourné et al. | Development of a novel bioactive formulation of vasoactive intestinal peptide in sterically stabilized liposomes | |
Benita et al. | Radiopaque liposomes: effect of formulation conditions on encapsulation efficiency | |
BRPI0615349A2 (pt) | composição farmacêutica compreendendo um quelador de ferro | |
EP3241565A2 (fr) | Nanostructure multi-lamellaire de type hybride de facteur de croissance épidermique et liposome et procédé de fabrication associé | |
KR101209496B1 (ko) | 나노입자 제제를 보관하는 방법 | |
Güthlein et al. | Pharmacokinetics and antitumor activity of vincristine entrapped in vesicular phospholipid gels | |
US9011924B2 (en) | Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery | |
WO2009072136A1 (fr) | Vecteurs de médicaments particulaires en tant qu'agents de désensibilisation | |
WO1991007973A1 (fr) | Emulsion grasse | |
JP2817883B2 (ja) | 高度に完全なリポソームおよびその製剤法と用途 | |
US10159646B2 (en) | Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery | |
CN103040764B (zh) | 一种盐酸平阳霉素脂质体注射剂 | |
EP3753549A1 (fr) | Formulation de doxorubicine liposomale, procédé de production d'une formulation de doxorubicine liposomale et utilisation d'une formulation de doxorubicine liposomale en tant que médicament |